Trials / Completed
CompletedNCT01446770
Evaluation of the Initial Safety and Efficacy of Keloid Lesions Treated With MF-4181
A Prospective, Randomized, Comparative Feasibility Study Evaluating the Initial Safety and Efficacy of Keloid Lesions Treated With MF-4181 Adjunctive to Surgical Scar Revision
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Halscion, Inc. · Industry
- Sex
- All
- Age
- 15 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to evaluate the initial safety and efficacy of MF-4181, a hydrogel scaffold, in the reduction of the volume, appearance, and/or symptoms associated with keloid scarring in subjects undergoing surgical revision of keloid scars.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hydrogel scaffold (MF-4181) | Following surgical removal of the ear keloid, the incision will be treated with MF-4181. |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2011-10-05
- Last updated
- 2012-03-13
Locations
1 site across 1 country: The Bahamas
Source: ClinicalTrials.gov record NCT01446770. Inclusion in this directory is not an endorsement.